Search The Web
Login / Join
Science & Tech
Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx
Inside Wall Street: Interest in Genomic Research Sector Heats Up Again
Big pharma heats up with high performance for drugs, earnings
Animal rights groups step up attacks against Novartis
Winners and losers: Ten headline-making M&A deals
Amgen jumps 15 percent on results of clinical trial
As swine flu becomes a pandemic, where are the vaccines?
Novartis strikes again: New drug shows blockbuster potential
Novartis grabs two growth segments in one deal: Generic and cancer drugs
Pharma Report: New drugs coming, but what about Pfizer?
Recommended For You
Reese Witherspoon emotionally recalls being sexually assaulted at 16, says this wa...
The Scaramucci Post just tweeted the most outrageous poll about the Holocaust
Bob Weinstein accused of sexual harassment by TV showrunner
Johnson & Johnson wins reversal of $72M verdict over talc cancer risks
US judge blocks latest Trump travel restrictions
U.S. diplomat warns to be 'prepared for the worst' right after N. Korean official ...
Russia probe: Senate asks Mike Flynn’s son for documents, testimony
20 cities where Americans have the longest commutes
More to Explore